Diabetes Management and Healthcare Resource Use When Intensifying from Basal Insulin to Basal-Bolus: A Survey of Type 2 Diabetes Patients

被引：0
|
作者：
Kathryn M. Pfeiffer
Amaury Basse
Xin Ying Lee
Laura Tesler Waldman
机构：
[1] The Brod Group,
[2] Novo Nordisk A/S,undefined
来源：
Diabetes Therapy | 2018年 / 9卷
关键词：
Basal-bolus insulin therapy; Diabetes management; Diabetes, type 2; Healthcare resource use; Insulin intensification;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1931 / 1944
页数：13
相关论文
共 50 条
  • [31] An Indirect Comparison of Basal Insulin Plus Once-Weekly Semaglutide and Fully Optimised Basal-Bolus Insulin in Type 2 Diabetes
    Lingvay, Ildiko
    Catarig, Andrei-Mircea
    Lawson, Jack
    Chubb, Barrie
    Gorst-Rasmussen, Anders
    Evans, Lyndon Marc
    DIABETES THERAPY, 2023, 14 (01) : 123 - 137
  • [32] THE COSTS OF INTENSIFYING TYPE 2 DIABETES PATIENTS TREATED WITH BASAL INSULIN TO BASAL IN COMBINATION WITH GLP-1: A PHYSICIAN SURVEY
    Pfeiffer, K. M.
    Basse, A.
    Brod, M.
    VALUE IN HEALTH, 2018, 21 : S74 - S74
  • [33] Quality Of Life, Hypoglycaemic Symptoms and Treatment Satisfaction in Patients with Type 2 Diabetes Receiving Basal-Bolus Insulin
    Ionova, T. I.
    Odin, V., I
    Nikitina, T. P.
    Kurbatova, K. A.
    DIABETES MELLITUS, 2015, 18 (04): : 48 - 58
  • [34] Insulin Degludec: Reduction of Hypoglycemia during Basal-Bolus Therapy in Patients with Diabetes Mellitus Type 1 or 2
    Luedemann, J.
    Merker, L.
    Milek, K.
    Kaiser, M.
    Wilhelm, B.
    DIABETOLOGIE UND STOFFWECHSEL, 2013, 8 (01) : 35 - 42
  • [35] A Review of Basal-Bolus Therapy Using Insulin Glargine and Insulin Lispro in the Management of Diabetes Mellitus
    Candido, Riccardo
    Wyne, Kathleen
    Romoli, Ester
    DIABETES THERAPY, 2018, 9 (03) : 927 - 949
  • [36] Efficacy and Safety of a Basal-Bolus Regimen of Basal Insulin Plus Insulin Glulisine in Patients With Type 2 Diabetes: A Pooled Analysis of 5 Clinical Trials
    Dailey, George
    Lin, Jay
    Wang, Edward
    DIABETES, 2012, 61 : A284 - A284
  • [37] Comparison of insulin lispro protamine suspension and insulin detemir in basal-bolus therapy in patients with Type 1 diabetes
    Chacra, A. R.
    Kipnes, M.
    Ilag, L. L.
    Sarwat, S.
    Giaconia, J.
    Chan, J.
    DIABETIC MEDICINE, 2010, 27 (05) : 563 - 569
  • [38] Achievement of Glycemic Targets when Switching from Basal-Bolus Therapy to V-Go for Insulin Delivery in Type 2 Diabetes
    Hundal, Ripu S.
    Kowalyk, Stephan
    Cases, Jane
    Al-Karadsheh, Amer
    Wakim, Amanda P.
    Doyle, Melissa
    Sink, John H., II
    Spence, Adrienne
    Brewer, Jamie L.
    Nikkel, Carla C.
    DIABETES, 2018, 67
  • [39] Basal-bolus or premixed? Shedding light on optimal insulin regime for type 1 diabetes
    Walton, Emma Louise
    BIOMEDICAL JOURNAL, 2018, 41 (06) : 337 - 339
  • [40] OPTIMAL REGIMENS OF THE BASAL-BOLUS INSULIN THERAPY IN ADOLESCENTS WITH TYPE 1 DIABETES MELLITUS
    Galkina, G. A.
    Voropay, A. A.
    Levkovich, M. A.
    Vorobiov, S. V.
    Komkova, M. V.
    Morozova, N. V.
    BYULLETEN SIBIRSKOY MEDITSINY, 2015, 14 (05): : 15 - U223
12345